Angiotensin II
Angiotensin Receptor Antagonists
Antihypertensive Agents
Diabetic Nephropathies
Hypertension

Candesartan

Candesartan is an angiotensin II receptor blocker commonly used in the management of hypertension, which is prevalent in various populations globally. This medication is notable for its effectiveness in treating hypertension, a condition impacting nearly 30% of the adult population in the United States. Candesartan is initially administered as a prodrug, candesartan cilexetil, which is hydrolyzed in the gastrointestinal tract during absorption. Beyond its primary indication, candesartan is often used off-label for several other conditions, including congestive heart failure, diabetic nephropathy, and postmyocardial infarction management. The drug’s mechanism of action involves blocking the angiotensin II receptor, leading to vasodilation and a reduction in blood pressure. This activity provides an in-depth exploration of the epidemiology, dosing, potential adverse effects, and monitoring strategies associated with candesartan. Healthcare professionals acquire essential insights to ensure the effective and safe use of this medication for patients requiring antihypertensive therapy and related indications. Notably, the emphasis is on empowering clinicians and highlighting the essential role of the interprofessional healthcare team. This activity aims to equip clinicians with the fundamental knowledge and tools to deliver excellent patient care during candesartan administration, thereby advancing patient outcomes and care standards.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.